About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Bendamustine hydrochloride
- Procedure number
- PSUSA/00003162/202001
- Regulatory outcome
- Variation
Documents
Bendamustine hydrochloride: List of nationally authorised medicinal products - PSUSA/00003162/202001
English (EN) (142.21 KB - PDF)
Bendamustine hydrochloride: CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00003162/202001
English (EN) (42.14 KB - PDF)
български (BG) (123.52 KB - PDF)
español (ES) (66.72 KB - PDF)
čeština (CS) (113.58 KB - PDF)
dansk (DA) (67.45 KB - PDF)
Deutsch (DE) (142.82 KB - PDF)
eesti keel (ET) (68.63 KB - PDF)
ελληνικά (EL) (115.48 KB - PDF)
français (FR) (40.58 KB - PDF)
hrvatski (HR) (106.19 KB - PDF)
íslenska (IS) (72.12 KB - PDF)
italiano (IT) (58.5 KB - PDF)
latviešu valoda (LV) (113.94 KB - PDF)
lietuvių kalba (LT) (111.68 KB - PDF)
magyar (HU) (112.14 KB - PDF)
Malti (MT) (116.37 KB - PDF)
Nederlands (NL) (65.34 KB - PDF)
norsk (NO) (64.61 KB - PDF)
polski (PL) (117.42 KB - PDF)
português (PT) (67.77 KB - PDF)
română (RO) (109.59 KB - PDF)
slovenčina (SK) (112.15 KB - PDF)
slovenščina (SL) (107.48 KB - PDF)
Suomi (FI) (66.68 KB - PDF)
svenska (SV) (65.82 KB - PDF)